PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -100.0% | 27 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $16,299,000 | -18.1% | 834,967 | +11.8% | 0.12% | -2.4% |
| Q3 2018 | $19,892,000 | -30.1% | 746,968 | -0.8% | 0.12% | -31.9% |
| Q2 2018 | $28,451,000 | +14.4% | 753,266 | -1.1% | 0.18% | +15.9% |
| Q1 2018 | $24,864,000 | – | 761,290 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |